Jiong Wu
Impact in
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Cancer Research 176
- Breast Cancer Treatment Studies 115
- Cancer Genomics and Diagnostics 29
- Oncology 136
- HER2/EGFR in Cancer Research 48
- Cancer Treatment and Pharmacology 33
- Cancer Cells and Metastasis 22
- Co-authors
- Gen‐Hong DiZhen‐Zhou ShenZhi‐Ming ShaoGuang‐Yu LiuKe‐Da YuJin-Song LuZhi-Ming ShaoSanford H. Barsky
- Journals
- Breast Cancer Research and Treatment (21 papers)PLoS ONE (12 papers)European Journal of Surgical Oncology (9 papers)Frontiers in Oncology (8 papers)Cancer Research (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jiong Wu
311 papers receiving 9.1k citations
Peers
Comparison fields: 5 of 156
- Cancer Research 3.7k
- Oncology 3.1k
- Pathology and Forensic Medicine 1.3k
- Molecular Biology 4.4k
- Immunology 708
Countries citing papers authored by Jiong Wu
This map shows the geographic impact of Jiong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiong Wu more than expected).
Fields of papers citing papers by Jiong Wu
This network shows the impact of papers produced by Jiong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiong Wu. The network helps show where Jiong Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiong Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 39 | |
| 11 | 2023 | 25 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 35 | |
| 15 | 2019 | 153 | |
| 16 | 2017 | 1 | |
| 17 | 2014 | 98 | |
| 18 | 2013 | 132 | |
| 19 | [Expression of CK5/6 and CK17 and its correlation with prognosis of triple-negative breast cancer patients]. | 2008 | 4 |
| 20 | Recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) induces human macrophage production of transforming growth factor-alpha. | 1991 | 6 |
About Jiong Wu
Jiong Wu is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Genetics and Molecular Biology, having authored 326 papers that have together received 9.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (115 papers), Breast Lesions and Carcinomas (58 papers), HER2/EGFR in Cancer Research (48 papers), Breast Implant and Reconstruction (43 papers), Cancer Treatment and Pharmacology (33 papers), Cancer Genomics and Diagnostics (29 papers), Cancer Cells and Metastasis (22 papers) and BRCA gene mutations in cancer (21 papers). The work is most often cited by research in Cancer Research (3.7k citations), Oncology (3.1k citations), Pathology and Forensic Medicine (1.3k citations), Molecular Biology (4.4k citations) and Immunology (708 citations). Jiong Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Gen‐Hong Di, Zhen‐Zhou Shen, Zhi‐Ming Shao, Guang‐Yu Liu, Ke‐Da Yu, Jin-Song Lu, Zhi-Ming Shao, Sanford H. Barsky, Yayun Chi and Zhen Shen. Their work appears in journals such as Breast Cancer Research and Treatment, PLoS ONE, European Journal of Surgical Oncology, Frontiers in Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.